Yahoo Finance • 8 months ago
Penumbra Inc's innovative medical devices continue to address significant unmet needs in neurovascular and peripheral vascular markets. Despite strong market presence, Penumbra faces intense competition and regulatory challenges that could... Full story
Yahoo Finance • 12 months ago
In the intricate dance of the stock market, insider transactions often attract the attention of investors seeking clues about a company's future performance. A recent transaction by Johanna Roberts, the Executive Vice President, General Co... Full story
Yahoo Finance • last year
Latest STRIKE-PE data show that computer assisted vacuum thrombectomy (CAVT) for the treatment of pulmonary embolism is safe and effective at reducing right heart strain; it also improved clinical and functional outcomes Penumbra's Indigo®... Full story
Yahoo Finance • last year
In this article, we discuss the 14 best multibagger stocks. To skip the global economic outlook and analysis of multibagger stocks, you can go directly to the 5 Best Multibagger Stocks to Buy for 2024. Global Economic Outlook The last th... Full story
Yahoo Finance • 2 years ago
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. In a perfect world, we'd like to see a company investing more capital into its business and ideally... Full story
Yahoo Finance • 2 years ago
In this article, we will take a look at the 15 biggest medical device companies in the world. If you want to skip our introduction to the industry, then take a look at 5 Biggest Medical Device Companies in the World. The medical device ma... Full story
Yahoo Finance • 2 years ago
SYDNEY, Australia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Omniscient Neurotechnology, the brain mapping company creating new possibilities in brain health, today announced the appointment of Barbara Nelson and Surbhi Sarna to its board of dir... Full story
Yahoo Finance • 2 years ago
Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names. While we will not be weighing in with fundamental analysis, we hope this pi... Full story